M. Duvic et al., CUTANEOUS T-CELL LYMPHOMA IN ASSOCIATION WITH SILICONE BREAST IMPLANTS, Journal of the American Academy of Dermatology, 32(6), 1995, pp. 939-942
Background: Cutaneous T-cell lymphoma (CTCL) is a chronic malignancy o
f helper T cells with the CD4 phenotype. It occurs less frequently in
young women but is increasing in incidence for unknown reasons. Silico
ne breast implants have been associated with T-cell-mediated autoimmun
e reactions. Objective: Our purpose was to suggest the hypothesis that
CTCL may arise after breast implants and that different patients with
CTCL may be stimulated by different antigens. Methods: Investigators
with many patients with CTCL were queried regarding the occurrence of
CTCL in women after breast implants. Results: Three cases of confirmed
CTCL after breast implants were identified and are reported. In one p
atient with Sezary syndrome and CTCL, the disease went into remission
after removal of implants, resolution of chronic staphylococcal infect
ion, and initiation of photopheresis and interferon alfa therapy. Anot
her patient had progressive disease. Conclusion: CTCL may occur in ass
ociation with breast implants in young female patients, but causality
is unknown. If CTCL is antigen driven, then it is likely to result fro
m several different antigens in different groups of patients.